Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions

The British Journal of Dermatology
S KangJ H Choi

Abstract

Calcipotriene is a synthetic analogue of 1,25-dihydroxyvitamin D3 established to be effective topically in the treatment of psoriasis. We investigated the early cellular and immunological events induced by calcipotriene in psoriasis. Thirty patients with moderate plaque-type psoriasis were randomly assigned to receive twice daily applications of either calcipotriene ointment 0.005% or matching vehicle for 6 weeks. Skin biopsies (6 mm) were performed from designated plaques at baseline and days 3 and 7. On these days and at weeks 2, 4 and 6, complete clinical evaluations were made in a double-blind fashion. Consistent with previous studies, significant clinical improvement (P < 0.05) in psoriasis was observed in patients receiving calcipotriene vs. those receiving vehicle by day 7 for scale and erythema, and by day 14 for thickness. No significant improvement, however, was seen on day 3. None of the immunohistological markers (CD1a, CD4, CD8, ICAM-1, VCAM-1, E-selectin, HLA-DR) semiquantitatively assessed in psoriatic plaques was significantly changed by calcipotriene treatment for 7 days. In the calcipotriene-treated group, interleukin (IL)-10 levels (pg/microgram of protein) increased by 57% from baseline (0.030 +/- 0.006; mea...Continue Reading

References

Dec 11, 1992·Science·A E KochR M Strieter
Sep 1, 1992·The Journal of Investigative Dermatology·A TuschilI Lindley
May 1, 1992·Journal of the American Academy of Dermatology·W J CunliffeJ P Ortonne
May 8, 1992·Biochemical Pharmacology·L Binderup
Jan 1, 1991·The Journal of Investigative Dermatology·M SticherlingE Christophers
Jul 1, 1991·The Journal of Investigative Dermatology·R GillitzerG Stingl
May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P ParronchiS Romagnani
May 15, 1991·Biochemical and Biophysical Research Communications·C G LarsenK Thestrup-Pedersen
Aug 1, 1988·The British Journal of Dermatology·K KragballeH Søgaard
Aug 1, 1994·International Immunology·C CauxJ Banchereau
Jun 1, 1995·The Journal of Steroid Biochemistry and Molecular Biology·J M Lemire
May 25, 1995·Biochemical and Biophysical Research Communications·B GesserC G Larsen
May 1, 1994·Baillière's Clinical Rheumatology·J N Barker
Jul 1, 1996·International Archives of Allergy and Immunology·E Christophers
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·M T CantornaH F DeLuca
Sep 17, 1996·Proceedings of the National Academy of Sciences of the United States of America·C NishigoriM L Kripke
Oct 1, 1996·The Journal of Investigative Dermatology·S BeissertR D Granstein

❮ Previous
Next ❯

Citations

Jul 31, 2003·Pharmacology & Therapeutics·C O Mendonça, A D Burden
Aug 22, 2002·International Immunopharmacology·Luciano Adorini
Apr 16, 2002·The British Journal of Dermatology·J MasonM J Cork
Apr 16, 2002·Clinical and Experimental Dermatology·D BayramgürlerM Ustün
Jan 29, 2000·International Journal of Dermatology·M V BalagonG P Walsh
Jan 15, 2005·Journal of the European Academy of Dermatology and Venereology : JEADV·V SchleyerR-M Szeimies
Dec 13, 2005·The Journal of Clinical Investigation·Emmanuel XystrakisCatherine M Hawrylowicz
Apr 30, 2002·American Journal of Clinical Dermatology·Jennifer Cather, Alan Menter
Nov 4, 2000·Expert Opinion on Investigational Drugs·D DiSepio, R A Chandraratna
Aug 12, 2009·Expert Opinion on Pharmacotherapy·Rosita SaracenoSergio Chimenti
Jul 24, 2004·The British Journal of Dermatology·T KormeiliP S Yamauchi
Oct 15, 2005·Hemodialysis International·Eric SeibertMartin K Kuhlmann
Mar 25, 2005·The British Journal of Dermatology·V Quekenborn-TrinquetC E M Griffiths
Jun 8, 2007·The British Journal of Dermatology·M T DytocP T Ting
Jan 21, 2015·International Journal of Dermatology·Teo SoleymaniJennifer Soung
Mar 31, 2005·Endocrine Reviews·Sunil NagpalRadhakrishnan Rathnachalam
Jun 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jan EhrchenAndreas Lengeling
Dec 19, 2015·Physiological Reviews·Sylvia ChristakosGeert Carmeliet
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Anne R MasonHelen Hancock
Jun 18, 2003·The Journal of Dermatology·Masahiro KiraKunihiko Yoshikawa
Jun 24, 2008·The Journal of Dermatological Treatment·Anna ZampettiPierluigi Amerio
Sep 6, 2003·International Journal of Dermatology·Namita Rath, Hemant Kumar Kar
Oct 4, 2008·International Journal of Immunopathology and Pharmacology·P Cordiali-FeiE Berardesca
Jun 19, 2007·Journal of the American Academy of Dermatology·Michael M JiaravuthisanChanny Y Muhn
Jul 21, 2001·Journal of Medicinal Chemistry·S M ThacherR A Chandraratna

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.